Bayer CropScience Supports the Battle against Malaria: LifeNet™ Mosquito Nets Now Available

Share Article

• User-friendly and even effective after 30 washes, providing more nights of protection • Delivery in African countries about to start

News Image
Our motivation was to set a new standard in bednet durability and to thereby increase the impact of malaria control programs for the benefit of those in need.

Bayer CropScience´s innovative LifeNet™ mosquito nets are now available. The company received all necessary regulatory approvals for large scale production. As a first step, the delivery of millions of LifeNet™ mosquito nets is about to start in African countries to support their ongoing fight against malaria. Registrations have been received in Malawi, Namibia and Zambia with further registrations pending. LifeNet™ represents a longer-lasting, user-friendly alternative to currently available nets.

Malaria, still one of the world’s deadliest diseases, has been eliminated in some parts of the world. Yet in certain parts of Sub-Saharan Africa, malaria infections have increased over the last three decades. According to the WHO, populations living in this region have the highest risk of acquiring malaria. Malaria significantly affects the quality of life of communities and impacts local economies by reducing the income of individuals and families, thus slowing economic growth. Malaria also threatens food security and rural development in already deprived regions, e.g. by causing losses in agricultural production.

“Our motivation was to set a new standard in bednet durability and to thereby increase the impact of malaria control programs for the benefit of those in need,” said Dr. Gunnar Riemann, Head of Bayer CropScience´s Environmental Science Division.

“LifeNet™ is the world´s first long-lasting polypropylene net, with deltamethrin incorporated deep into the fiber providing a unique combination of efficacy, strength and softness – a new tool in the fight against malaria,” added Nadim Mohr, Commercial Operations Manager at Bayer Environmental Science and responsible for Sub-Saharan Africa. “LifeNet™ is the first net which is recognized by the World Health Organization to be effective even after 30 washes – providing more, effective nights of protection.”

Bayer CropScience has more than 50 years of experience in the field of malaria vector control (http://www.vectorcontrol.bayer.com). In keeping with the company´s commitment to sustainable development, LifeNet™ was created with an emphasis on ensuring a responsible social, economic and environmental impact. It supports the sustainable development of African countries threatened by this controllable disease.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 7.255 billion (2011), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com.

Note to editors:
Photo material in print quality and a graphic can be downloaded from the internet at http://www.press.bayer.com and http://www.press.bayercropscience.com.

The following LifeNet™ video material can be found on YouTube: “Bayer´s contribution to fight back malaria” and “Combating Malaria”.

Contact:
Utz Klages, Tel. +49 2173 38-3125
E-Mail: utz.klages(at)bayer(dot)com

Find more information at http://www.bayercropscience.com.
kgs    (2012-0182E)

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Utz Klages
Bayer Corporation
+49 2173 38-3125
Email >
Visit website